The Benefits of Genetic Testing for Patients with CDKL5 Deficiency Disorder and Other Rare Genetic Epilepsies
Health And Wellness
Brandpoint (BPT)  
August 14, 2024

The Benefits of Genetic Testing for Patients with CDKL5 Deficiency Disorder and Other Rare Genetic Epilepsies

(BPT) - CDKL5 deficiency disorder, one of the most common genetic epilepsies, is estimated to occur in approximately 100 newborns in the U.S. per year.

avatar profile Olean Times Herald

Olean Times Herald


Local & Social